Literature DB >> 29193826

Validation of eye-tracking measures of social attention as a potential biomarker for autism clinical trials.

Michael Murias1,2, Samantha Major2,3, Katherine Davlantis2,3, Lauren Franz2,3, Adrianne Harris2, Benjamin Rardin2,3, Maura Sabatos-DeVito2,3, Geraldine Dawson1,2,3.   

Abstract

Social communication impairments are a core feature of autism spectrum disorder (ASD), and this class of symptoms is a target for treatments for the disorder. Measures of social attention, assessed via eye-gaze tracking (EGT), have been proposed as an early efficacy biomarker for clinical trials targeting social communication skills. EGT measures have been shown to differentiate children with ASD from typical children; however, there is less known about their relationships with social communication outcome measures that are typically used in ASD clinical trials. In the present study, an EGT task involving viewing a videotape of an actor making bids for a child's attention was evaluated in 25 children with ASD aged 24-72 months. Children's attention to the actor during the dyadic bid condition measured via EGT was found to be strongly associated with five well-validated caregiver-reported outcome measures that are commonly used to assess social communication in clinical trials. These results highlight the convergent validity of EGT measures of social attention in relation to caregiver-reported clinical measures. EGT holds promise as a non-invasive, quantitative, and objective biomarker that is associated with social communication abilities in children with ASD. Autism Res 2018, 11: 166-174.
© 2017 International Society for Autism Research, Wiley Periodicals, Inc. LAY SUMMARY: Eye-gaze tracking (EGT), an automated tool that tracks eye-gaze patterns, might help measure outcomes in clinical trials investigating interventions to treat autism spectrum disorders. In this study, an EGT task was evaluated in children with ASD, who watched a video with an actor talking directly to them. Patterns of eye-gaze were associated with caregiver-reported measures of social communication that are used in clinical trials. We show EGT may be a promising objective tool measuring outcomes. © 2017 International Society for Autism Research, Wiley Periodicals, Inc.

Entities:  

Keywords:  autism spectrum disorder; biomarker; clinical trials; eye movement; eye-tracking

Mesh:

Substances:

Year:  2017        PMID: 29193826     DOI: 10.1002/aur.1894

Source DB:  PubMed          Journal:  Autism Res        ISSN: 1939-3806            Impact factor:   5.216


  26 in total

1.  Do minimally verbal and verbally fluent individuals with autism spectrum disorder differ in their viewing patterns of dynamic social scenes?

Authors:  Daniela Plesa Skwerer; Briana Brukilacchio; Andrea Chu; Brady Eggleston; Steven Meyer; Helen Tager-Flusberg
Journal:  Autism       Date:  2019-05-09

2.  Promoting social attention in 3-year-olds with ASD through gaze-contingent eye tracking.

Authors:  Quan Wang; Carla A Wall; Erin C Barney; Jessica L Bradshaw; Suzanne L Macari; Katarzyna Chawarska; Frederick Shic
Journal:  Autism Res       Date:  2019-08-30       Impact factor: 5.216

Review 3.  Towards a Multivariate Biomarker-Based Diagnosis of Autism Spectrum Disorder: Review and Discussion of Recent Advancements.

Authors:  Troy Vargason; Genevieve Grivas; Kathryn L Hollowood-Jones; Juergen Hahn
Journal:  Semin Pediatr Neurol       Date:  2020-03-05       Impact factor: 1.636

4.  Identifying prognostic markers in autism spectrum disorder using eye tracking.

Authors:  Elizabeth C Bacon; Adrienne Moore; Quimby Lee; Cynthia Carter Barnes; Eric Courchesne; Karen Pierce
Journal:  Autism       Date:  2019-10-24

5.  Distance from Typical Scan Path When Viewing Complex Stimuli in Children with Autism Spectrum Disorder and its Association with Behavior.

Authors:  Elena J Tenenbaum; Samantha Major; Kimberly L H Carpenter; Jill Howard; Michael Murias; Geraldine Dawson
Journal:  J Autism Dev Disord       Date:  2021-01-02

6.  Random and Short-Term Excessive Eye Movement in Children with Autism During Face-to-Face Conversation.

Authors:  Zhong Zhao; Jiayi Xing; Xiaobin Zhang; Xingda Qu; Xinyao Hu; Jianping Lu
Journal:  J Autism Dev Disord       Date:  2021-08-28

Review 7.  Gaze and social functioning associations in autism spectrum disorder: A systematic review and meta-analysis.

Authors:  Jacqueline A Riddiford; Peter G Enticott; Alex Lavale; Caroline Gurvich
Journal:  Autism Res       Date:  2022-05-20       Impact factor: 4.633

8.  Eye-Tracking in Infants and Young Children at Risk for Autism Spectrum Disorder: A Systematic Review of Visual Stimuli in Experimental Paradigms.

Authors:  Ann M Mastergeorge; Chanaka Kahathuduwa; Jessica Blume
Journal:  J Autism Dev Disord       Date:  2021-08

9.  Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder.

Authors:  Andrew W Zimmerman; Kanwaljit Singh; Susan L Connors; Hua Liu; Anita A Panjwani; Li-Ching Lee; Eileen Diggins; Ann Foley; Stepan Melnyk; Indrapal N Singh; S Jill James; Richard E Frye; Jed W Fahey
Journal:  Mol Autism       Date:  2021-05-25       Impact factor: 7.509

10.  Visual Preference for Biological Motion in Children and Adults with Autism Spectrum Disorder: An Eye-Tracking Study.

Authors:  Dzmitry A Kaliukhovich; Nikolay V Manyakov; Abigail Bangerter; Seth Ness; Andrew Skalkin; Matthew Boice; Matthew S Goodwin; Geraldine Dawson; Robert Hendren; Bennett Leventhal; Frederick Shic; Gahan Pandina
Journal:  J Autism Dev Disord       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.